48 results
8-K
EX-99.1
MRNS
Marinus Pharmaceuticals Inc
5 Dec 22
Other Events
9:00am
Field Insights Lisa Lejuwaan, VP, Sales ZTALMY Market Access and Patient Services Update Paul Voss, VP, Access & Policy ZTALMY Customer Engagement … , including 8 CDD Centers of Excellence and 40 National Epilepsy Centers Continued engagement with key CDD advocacy groups and research organizations
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
21 Mar 22
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results
7:16am
advocacy engagement and education 9
©2022 Marinus Pharmaceuticals. All Rights Reserved I CDD Targeted Sales Force Team & Key Account Strategy 10 CDD … community engagement planning underway Planned start in 2H 2022 Benzodiazepine Administered IV AEDs (antiepileptic drugs) IV Anesthetics (Medically
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
7 Nov 22
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2022 Financial Results
4:01pm
key hospitals and centers, including 8 CDD Centers of Excellence and 40 National Epilepsy Centers Continued engagement with key CDD advocacy groups … Exception From Informed Consent community engagement planning underway Planned start in 2H 2022 Benzodiazepine Administered IV AEDs (antiepileptic
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
11 Aug 22
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
7:33am
Epilepsy Centers Continued engagement with key CDD advocacy groups and research organizations Significant interactions with State Medicaid and other … Consent community engagement planning underway Planned start in 2H 2022 Benzodiazepine Administered IV AEDs (antiepileptic drugs) IV Anesthetics
8-K
EX-99.2
MRNS
Marinus Pharmaceuticals Inc
11 May 23
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2023 Financial Results
7:03am
Exception From Informed Consent community engagement planning underway Planned start in 2H 2022 Benzodiazepine Administered IV AEDs (antiepileptic drugs) IV … New dosing paradigm Exception From Informed Consent community engagement underway Sequential subject cohorts will evaluate dose and duration
8-K
cb8hcia
17 Jun 20
Changes in Registrant's Certifying Accountant
5:22pm
8-K
EX-99.2
or30tup9pzii9if932
10 Aug 23
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter 2023 Financial Results
7:10am
8-K
EX-99.2
993k1rzgo
9 Nov 21
Marinus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
7:03am
10-K
EX-10.3
b6tt40n zt
12 Mar 15
Annual report
12:00am
8-K
EX-10.1
rz50yj
29 Oct 19
Marinus Pharmaceuticals Appoints Joe Hulihan, M.D., as Chief Medical Officer
1:31pm
10-K
EX-10.4
39mug qamako
12 Mar 15
Annual report
12:00am
8-K
EX-10.1
ab8b 3z5m68fchz
8 Aug 19
Marinus Pharmaceuticals Provides Business Update and Reports Second Quarter Financial Results
4:34pm
8-K
EX-99.2
6klec6zv
9 Mar 21
Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter 2020 Financial Results
7:05am
8-K
EX-99.1
5ppqb
12 May 22
Marinus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
4:02pm
8-K
EX-99.2
zjs9t3pdqphmrp4wlc6
7 Dec 20
Other Events
8:03am